Peripheral blood tumor biomarker screening and significance in clinical practice / 中华检验医学杂志
Chinese Journal of Laboratory Medicine
; (12): 961-964, 2013.
Article
em Zh
| WPRIM
| ID: wpr-439437
Biblioteca responsável:
WPRO
ABSTRACT
Rapid development of personalized medicine in cancer treatments needs urgent support of proper tumor biomarkers.Comparing to tissue tests,serum/plasma tumor biomarkers show advantages in easy sample collection and flexibility of detecting methods.Nowadays,large scales of investigations have discovered sufficient blood tumor biomarkers for preclinical diagnosis and evaluation of clinical treatment or prognosis,with the development of screening techniques and strategies.Moreover,tremendous promotion would appear in cancer diagnosis and treatment with future profound investigation and rigorous verification from clinical practice.
Texto completo:
1
Base de dados:
WPRIM
Tipo de estudo:
Diagnostic_studies
/
Screening_studies
Idioma:
Zh
Revista:
Chinese Journal of Laboratory Medicine
Ano de publicação:
2013
Tipo de documento:
Article